Archive · 23 Jan 2026
17 Drug Samples in Telangana Fail Quality Tests
Recently, some medicine samples in Telangana were tested and found to not meet quality standards.
These medicines include common ones like pantoprazole and diclofenac.
The tests were done by the Central Drugs Standard Control Organisation (CDSCO) and the Drugs Control Laboratory of Telangana (DCLT).
The medicines failed because they had issues like wrong amounts of ingredients, wrong labels, or too many impurities.
The manufacturers of these medicines are from different states across India.
The health officials are taking action against the companies that made these medicines to make sure they follow the rules.
17 drug samples in Telangana were found not of standard quality (NSQ) by CDSCO and DCLT.
12 samples were identified by CDSCO laboratories, and 5 by DCLT.
Commonly used medicines like pantoprazole and diclofenac were among those that failed the tests.
Samples failed due to issues like dissolution, description, assay, impurity levels, or misbranding.
Manufacturers of the NSQ drugs are located across multiple states, including Telangana, Himachal Pradesh, and Tamil Nadu.
- Who
- Central Drugs Standard Control Organisation (CDSCO) and Drugs Control Laboratory of Telangana (DCLT)
- What
- 17 drug samples found not of standard quality (NSQ)
- When
- During recent testing (specific month not mentioned)
- Where
- Telangana, India
- Why
- Samples failed quality tests related to dissolution, description, assay, impurity levels, or misbranding
- Total NSQ Samples
- 17
- CDSCO-Identified Samples
- 12
- DCLT-Identified Samples
- 5
- Common Drugs Affected
- Pantoprazole, Cefpodoxime Proxetil, Diclofenac Potassium, Aceclofenac–Paracetamol, Pregabalin with Nortriptyline
- Testing Standards
- Indian Pharmacopoeia (IP) and United States Pharmacopoeia (USP)
- Manufacturers' Locations
- Telangana, Himachal Pradesh, Punjab, Tamil Nadu, Puducherry, Haryana, Uttarakhand
- Common Issues
- Dissolution, Description, Assay, Impurity Levels, Misbranding, Excess Ethylene Glycol, Diethylene Glycol
- Regulatory Action
- Action initiated under the Drugs and Cosmetics Act